Cardiff Oncology, Inc. - Common Stock (CRDF)
4.0300
+0.0600 (1.51%)
Cardiff Oncology Inc is a biotechnology company focused on developing innovative cancer therapies aimed at treating solid tumors
The company is dedicated to uncovering new treatment options for patients through its proprietary drug candidates and advanced research platforms. By leveraging scientific expertise and clinical research, Cardiff Oncology aims to address significant unmet needs in oncology, with an emphasis on enhancing patient outcomes and quality of life. Through collaboration with healthcare professionals and ongoing clinical trials, the company strives to bring novel therapeutics to market and contribute to the evolving landscape of cancer treatment.
Frequently Asked Questions
Is Cardiff Oncology, Inc. - Common Stock publicly traded?
Yes, Cardiff Oncology, Inc. - Common Stock is publicly traded.
What exchange does Cardiff Oncology, Inc. - Common Stock trade on?
Cardiff Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cardiff Oncology, Inc. - Common Stock?
The ticker symbol for Cardiff Oncology, Inc. - Common Stock is CRDF on the Nasdaq Stock Market
What is the current price of Cardiff Oncology, Inc. - Common Stock?
The current price of Cardiff Oncology, Inc. - Common Stock is 4.030
When was Cardiff Oncology, Inc. - Common Stock last traded?
The last trade of Cardiff Oncology, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Cardiff Oncology, Inc. - Common Stock?
The market capitalization of Cardiff Oncology, Inc. - Common Stock is 159.40M
How many shares of Cardiff Oncology, Inc. - Common Stock are outstanding?
Cardiff Oncology, Inc. - Common Stock has 39.55M shares outstanding.